Belimumab Phase I Study in Chinese Subjects With Systemic Lupus Erythematosus
Clinical trial NCT02880852 · COMPLETED
Trial details
- NCT number
- NCT02880852
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-23
- Primary completion
- 2017-09-08
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.